Erasmus Medical University Center
Erasmus Medical University Center
Rotterdam, Netherlands1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis | Disease Attributes, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, brain disorder, central nervous system disorder, encephalitis, immune system disorder, nervous system disorder | Recruiting | Phase 2 | 2025-07-01 | NCT04372615 |